Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes

Clinical trial NCT05918055 · TERMINATED

Trial details

NCT number: NCT05918055
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2023-11-14
Primary completion: 2025-03-10
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.